March 26, 2020
***MADRC CORONAVIRUS UPDATES***
Due to concerns surrounding COVID-19, we are taking every precaution to protect our research participants, study partners, and staff. We have shut down our in-house research operations, including clinical trials. Our staff are working remotely from their homes and participants and study partners are not coming in for visits. For some studies, we are continuing to perform remote visits that consist of either phone calls with our staff or computerized tests that can be done from home. Our dedication to finding more effective treatments and a cure for Alzheimer’s disease continues as always, however we must focus on the medical crisis at hand and follow all recommended guidelines to keep people safe.
We do not know yet when we will resume normal operations. We are evaluating the situation on a weekly basis and are available via phone and email in the meantime.
Partners Healthcare has set up a COVID-19 hotline for clinicians, patients and the public at 617-724-7000. For the most accurate updates on COVID-19, visit: CDC.gov and/or WHO.int
September 18, 2019
2021 Massachusetts General Hospital Clinical Fellowship in Dementia
The Massachusetts Alzheimer's Disease Research Center (ADRC) is pleased to announce an opening for a two-year Clinical Fellowship in Dementia at the Massachusetts General Hospital (MGH) and related institutions beginning July 1, 2021.
The goal of the non-degree program is to introduce exceptionally-qualified individuals to the successes and demands of a clinical career in dementia and related neurodegenerative diseases, and to provide an unparalleled foundation for potential leadership roles in academic medicine, industry or related fields.
More information is attached.
Fellowship application deadline: July 1, 2020
September 2, 2019
Biogen Aducanumab
Thank you for being in touch about the recent Biogen announcement. We understand you have many questions about it and thank you for your patience. At this time, the information we have is similar to what you have read and heard.
There is a scientific meeting scheduled for December at which more data will be presented by the company. We expect to have more information after this meeting and will keep our patients and their family members updated as information continues to become available. We are working on providing live updates on our website and will share the information to access this as soon as we have it. The aducanumab trial is not currently enrolling patients.
June 2, 2017
2017 Center of Excellence for Delirium in Aging: Research, Training and Educational Enhancement Delirium Research Boot Camp
Our colleagues at the Center of Excellence for Delirium in Aging: Research, Training & Educational Enhancement (CEDARTREE) are offering their 5th 'delirium boot camp' in Boston from November 1-3, 2017 and we'll love to help them get the word out:
The 3-day intensive course on delirium research will be held at the Inn at the Longwood Medical Center (342 Longwood Avenue, Boston, MA 02115) and recognized experts in the field will discuss cutting-edge research approaches, from assessment and methodology to novel technologies and interventions. Attendees will also have the opportunity to network with world-renowed experts in delirium and related fields.
More information regarding the boot camp and eligibility to attend may be found at https://deliriumnetwork.org/2017-delirium-boot-camp/.
A copy of the boot camp's application form is attached.
April 3, 2017
Network for Investigation of Delirium across the U.S. (NIDUS): Call for Pilot Proposals on Delirium Research
The Network for Investigation of Delirium across the U.S. (NIDUS) is offering two $50,000 pilot grants for proposals related to delirium research. The purpose of these awards is to encourage innovative research that will advance investigation in delirium and lead to future grant funding.
Applications are due on Tuesday, August 15th, 2017, 5:00pm EST.
Proposals must be related to delirium research in the following priority areas:
- Risk factors, prognosis, outcomes
- Pathophysiology, mechanisms, biomarkers, genomics and other-'omics' approaches
- Diagnostic tools and phenomenology
- Clinical interventions for prevention and treatment
Two application treaks are available; junior investigator track and established investigator track.
Please visit the NIDUS website for more information on eligibility and application requirements. An announcement flyer is attached.
March 17, 2017
2018 Massachusetts General Hospital Clinical Fellowship in Dementia
The Massachusetts Alzheimer's Disease Research Center (ADRC) is pleased to announce an opening for a two-year Clinical Fellowship in Dementia at the Massachusetts General Hospital (MGH) and related institutions beginning July 1, 2018.
The goal of the non-degree program is to introduce exceptionally-qualified individuals to the successes and demands of a clinical career in dementia and related neurodegenerative diseases, and to provide an unparalleled foundation for potential leadership roles in academic medicine, industry or related fields.
More information is attached.
Fellowship application deadline: EXTENDED from July 1, 2017 to July 31, 2017
March 14, 2017
2017 Call for Pilot Projects
The Massachusetts Alzheimer’s Disease Research Center (“MADRC”) is pleased to announce a Call for pilot project proposals on Alzheimer’s disease (AD) and related dementias for funding from April 1, 2017 - March 31, 2018.
The Call is open to investigators from within the Harvard community – including the Harvard-affiliated hospitals and institutions - with priority given first to junior investigators, then to senior investigators who are new to AD and related dementias research and finally, to established investigators with a new line of such research that lacks funding.
The MADRC anticipates that up to 3 awards in the direct cost amount of up to $40,000 per project will be awarded for the aforementioned 1-year funding period.
More details regarding the Call is attached.
Applications due: Wednesday, December 28, 2016
Recipients announced: Wednesday January 11, 2017
Awards start: April 1, 2017
March 14, 2017
Call for Applications: 2016 Neurodegenerative Diseases Pilot Study Grants Program
The Harvard NeuroDiscovery Center (“HNDC”) and the Massachusetts Alzheimer’s Disease Research Center (“MADRC”) are co-funding novel ideas for pilot projects aimed at understanding and developing treatments for neurodegenerative diseases. Together, we are pleased to announce a joint call for pilot study applications from investigators within the Harvard community, including the affiliated hospitals and institutions.
Grants with a dollar value up to $40,000 (direct costs) will be awarded for the duration of one year. This award cycle anticipates funding between five and eight awards.
Anticipated Schedule of Deadlines and Reviews
Request for Proposals announced: October 9, 2015
Applications due: November 20, 2015
Recipients announced: January 8, 2016
Awards start: April 1, 2016
More information is attached.
March 14, 2017
Call for Applications: 2015 Neurodegenerative Diseases Pilot Study Grants Program
The Massachusetts Alzheimer’s Disease Research Center (“MADRC”) and the Harvard NeuroDiscovery Center (“HNDC”) are co-funding novel ideas for pilot projects aimed at understanding and developing treatments for neurodegenerative diseases. Together, we are pleased to announce a joint call for pilot study applications from investigators within the Harvard community, including Harvard-affiliated hospitals and institutions.
Grants with a dollar value up to $40,000 (direct costs) will be awarded for the duration of one year. This award cycle anticipates funding between three and six awards. More information is attached.
Applications due: December 10, 2014
Recipients announced: January 15, 2015
Awards start: April 1, 2015
March 14, 2017
2015 Massachusetts General Hospital Clinical Fellowship in Dementia
The Massachusetts Alzheimer's Disease Research Center (ADRC) is pleased to announce an opening for a two-year Clinical Fellowship in Dementia at the Massachusetts General Hospital (MGH) and related institutions beginning July 1, 2015.
The goal of the non-degree program is to introduce exceptionally-qualified individuals to the successes and demands of a clinical career in dementia and related neurodegenerative diseases, and to provide an unparalleled foundation for potential leadership roles in academic medicine, industry or related fields.
More information is attached.
Fellowship application deadline: February 1, 2015